COVID‐19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin?-Reference-Cited by-同舟云学术

COVID‐19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin?

Author:

Saeedi‐Boroujeni Ali¹²³^ORCID,Mahmoudian‐Sani Mohammad‐Reza⁴^ORCID,Bahadoram Mohammad⁴^ORCID,Alghasi Arash⁴^ORCID

Affiliation:

1. Department of Immunology Faculty of Medicine Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran

2. Abadan School of Medical Sciences Abadan Iran

3. ImmunologyToday Universal Scientific Education and Research Network (USERN) Tehran Iran

4. Thalassemia and Hemoglobinopathy Research Center Health Research Institute Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

Reference66 articles.

4. The landscape of lung bronchoalveolar immune cells in COVID‐19 revealed by single‐cell RNA sequencing;Liao M;medRxiv.,2020

5. A review on pharmacological effects and therapeutic properties of curcumin;Modaresi M;J Med Plants.,2017

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Curcumin as a pharmaceutical leader;Curcumin-Based Nanomedicines as Cancer Therapeutics;2024